Slingshot Pharma offers 21 CFR Part 11 inventory software that helps pharmaceutical companies manage inventory while staying compliant with FDA regulations. The software includes features like electronic records, electronic signatures, and audit trails to keep data secure and accurate. It also supports batch tracking and inventory monitoring, making it easier for businesses to control stock, maintain traceability, and manage pharmaceutical operations efficiently.
-
2 Articles
-
1 Photos
-
0 Vidéos
-
Habitant Dedham
-
Du Massachusetts
-
10/09/2007
-
Suivi par 0 membre
Mises à jour récentes
-
Electronic batch records help pharmaceutical manufacturers replace paper-based documentation with digital records of production activities. This article explains how electronic batch records improve data accuracy, traceability, documentation control, and regulatory compliance. It also highlights how pharmaceutical software supports real-time production monitoring, reduces manual errors, and simplifies batch review while maintaining reliable manufacturing records.
Visit - https://www.slingshotpharma.com/blog/electronic-batch-records-pharmaElectronic batch records help pharmaceutical manufacturers replace paper-based documentation with digital records of production activities. This article explains how electronic batch records improve data accuracy, traceability, documentation control, and regulatory compliance. It also highlights how pharmaceutical software supports real-time production monitoring, reduces manual errors, and simplifies batch review while maintaining reliable manufacturing records. Visit - https://www.slingshotpharma.com/blog/electronic-batch-records-pharma
WWW.SLINGSHOTPHARMA.COMElectronic Batch Records in Pharma: Benefits & ChallengesLearn how electronic batch records improve data integrity, reduce manual errors, speed up batch review, and support compliance in pharmaceutical manufacturing.0 Commentaires 0 Parts 224 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter! -
0 Commentaires 0 Parts 62 Vue 0 Aperçu
Plus de lecture